Board Meeting21 Jul 2026, 03:59 pm
Senores Pharmaceuticals Board Meeting on July 27, 2026
AI Summary
Senores Pharmaceuticals Ltd has announced that its Board of Directors will convene on July 27, 2026. The primary agenda items include the consideration and approval of the unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. The company also noted that the trading window for dealing in its securities, which was closed from July 1, 2026, will remain shut until 48 hours after the financial results are approved and submitted to the stock exchanges. This aligns with the company's Insider Trading Code.
Key Highlights
- Board meeting scheduled for July 27, 2026.
- To approve Q1 FY27 unaudited financial results.
- Trading window closure extended post-results announcement.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from SENORES